Autopsy report · NCT02623504

DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder

“No apparent therapeutic effects that was superior to placebo”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 2 years before it stopped.
• 17 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Validus Pharmaceuticals

Sponsor type

Industry

Conditions

Bipolar Disorder

Interventions

Carbamazepine; Placebo

Participants

17

Sites

4

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.